|
CEP78 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.56550394448641E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.87390000475574E-09 |
| Normal-vs-Stage2 |
3.03089999997841E-06 |
| Normal-vs-Stage3 |
2.33779999803119E-08 |
| Normal-vs-Stage4 |
1.43489999882007E-08 |
| Stage1-vs-Stage2 |
5.933200E-01 |
| Stage1-vs-Stage3 |
3.385200E-01 |
| Stage1-vs-Stage4 |
1.137450E-01 |
| Stage2-vs-Stage3 |
8.752600E-01 |
| Stage2-vs-Stage4 |
4.192600E-01 |
| Stage3-vs-Stage4 |
4.536200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.49449996611884E-09 |
| Normal-vs-AfricanAmerican |
3.234100E-04 |
| Normal-vs-Asian |
1.35919999999512E-06 |
| Caucasian-vs-AfricanAmerican |
9.941200E-01 |
| Caucasian-vs-Asian |
9.156200E-01 |
| AfricanAmerican-vs-Asian |
9.409800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.24069998719278E-09 |
| Normal-vs-Female |
9.79090031272278E-10 |
| Male-vs-Female |
4.993000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.02989999972714E-07 |
| Normal-vs-Age(41-60Yrs) |
9.77339986718562E-10 |
| Normal-vs-Age(61-80Yrs) |
1.72620000515877E-08 |
| Normal-vs-Age(81-100Yrs) |
2.956000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.253600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.801200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.079360E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.540400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.249200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.333200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.015050E-01 |
| Classical-VS-Follicular |
5.797600E-04 |
| Classical-VS-Other |
5.420800E-01 |
| Classical-VS-Normal |
8.21279999563274E-08 |
| Tall-VS-Follicular |
5.639200E-01 |
| Tall-VS-Other |
8.109800E-01 |
| Tall-VS-Normal |
1.1649000000169E-06 |
| Follicular-VS-Other |
6.041400E-01 |
| Follicular-VS-Normal |
1.20550014415244E-10 |
| Other-VS-Normal |
1.416420E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.66690019962357E-10 |
| Normal-vs-N1 |
3.3931999998682E-07 |
| N0-vs-N1 |
7.041000E-01 |
|
|
